C. Meacham Harrell

2.1k citations

24 papers · 998 indexed · h-index 16

Cognitive Neuroscience top 5%
Endocrine and Autonomic Systems top 1%
Experimental and Cognitive Psychology top 2%
Molecular Biology
Cellular and Molecular Neuroscience top 10%

Co-authors: Christopher J. Winrow John J. Renger Paul J. Coleman Anthony L. Gotter Susan L. Garson Duane R. Reiss Steven V. Fox Pamela L. Tannenbaum
Topics: Sleep and Wakefulness Research (13 papers)Sleep and related disorders (11 papers)Circadian rhythm and melatonin (10 papers)
Cited by: Endocrine and Autonomic Systems Experimental and Cognitive Psychology Cognitive Neuroscience
Journals: Journal of the American Chemical Society Scientific Reports Biochemical and Biophysical Research Communications
Partner nations: United States

In The Last Decade

C. Meacham Harrell

24 papers receiving 969 citations

Peers

Countries citing papers authored by C. Meacham Harrell

Since Specialization

Citations

This map shows the geographic impact of C. Meacham Harrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Meacham Harrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Meacham Harrell more than expected).

Fields of papers citing papers by C. Meacham Harrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Meacham Harrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Meacham Harrell. The network helps show where C. Meacham Harrell may publish in the future.

Co-authorship network of co-authors of C. Meacham Harrell

This figure shows the co-authorship network connecting the top 25 collaborators of C. Meacham Harrell. A scholar is included among the top collaborators of C. Meacham Harrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Meacham Harrell. C. Meacham Harrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Magnetic resonance imaging detects white adipose tissue beiging in mice following PDE10A inhibitor treatment 2023 ·Journal of Lipid Research ·Michal R. Tomaszewski,Xiangjun Meng,Hyking Haley,C. Meacham Harrell,Terrence McDonald,Corin O. Miller,Sean M. Smith	4
2	Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man 2016 ·Scientific Reports ·Anthony L. Gotter,Mark S. Forman,C. Meacham Harrell,Joanne Stevens,Vladimir Svetnik,Ka Lai Yee,Xiaodong Li,Anthony J. Roecker,Steven V. Fox,Pamela L. Tannenbaum,Susan L. Garson,Inge De Lepeleire,Nicole Calder,Laura Rosen,Arie Struyk,Paul J. Coleman,W. Joseph Herring,John J. Renger,Christopher J. Winrow	67
3	Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements 2015 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Swati P. Mercer,Jeffrey M. Bergman,Kevin F. Gilbert,Scott D. Kuduk,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Pamela L. Tannenbaum,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	14
4	Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties 2015 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Kuduk,(unknown),(unknown),Joseph G. Bruno,Mark H. Pausch,Julie A. O’Brien,Tamara D. Cabalu,Joanne Stevens,(unknown),Pamela L. Tannenbaum,Susan L. Garson,Alan T. Savitz,C. Meacham Harrell,Anthony L. Gotter,Christopher J. Winrow,John J. Renger,Paul J. Coleman	15
5	Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis 2014 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Roecker,Swati P. Mercer,C. Meacham Harrell,Susan L. Garson,Steven V. Fox,Anthony L. Gotter,Thomayant Prueksaritanont,Tamara D. Cabalu,Donghui Cui,Wei Lemaire,Christopher J. Winrow,John J. Renger,Paul J. Coleman	9
6	Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant 2014 ·Bioorganic & Medicinal Chemistry Letters ·Izzat T. Raheem,Michael J. Breslin,Joseph G. Bruno,Tamara D. Cabalu,Andrew Cooke,Christopher D. Cox,Donghui Cui,Susan L. Garson,Anthony L. Gotter,Steven V. Fox,C. Meacham Harrell,Scott D. Kuduk,Wei Lemaire,Thomayant Prueksaritanont,John J. Renger,Craig A. Stump,Pamela L. Tannenbaum,Peter D. Williams,Christopher J. Winrow,Paul J. Coleman	17
7	The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold 2013 ·BMC Neuroscience ·Anthony L. Gotter,Christopher J. Winrow,(unknown),Susan L. Garson,Steven V. Fox,(unknown),C. Meacham Harrell,Donghui Cui,Ka Lai Yee,(unknown),Joanne Stevens,Alan T. Savitz,Pamela L. Tannenbaum,Spencer J. Tye,Terrence P. McDonald,(unknown),Scott D. Kuduk,Jason M. Uslaner,Paul J. Coleman,John J. Renger	76
8	Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Swati P. Mercer,Anthony J. Roecker,Susan L. Garson,Duane R. Reiss,C. Meacham Harrell,Kathy Murphy,Joseph G. Bruno,Rodney A. Bednar,Wei Lemaire,Donghui Cui,Tamara D. Cabalu,Cuyue Tang,Thomayant Prueksaritanont,George D. Hartman,Steven D. Young,Christopher J. Winrow,John J. Renger,Paul J. Coleman	19
9	Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia 2011 ·Neuropharmacology ·Christopher J. Winrow,Anthony L. Gotter,Christopher D. Cox,Pamela L. Tannenbaum,Susan L. Garson,Scott M. Doran,Michael J. Breslin,John D. Schreier,Steven V. Fox,C. Meacham Harrell,Joanne Stevens,Duane R. Reiss,Donghui Cui,Paul J. Coleman,John J. Renger	109
10	Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman,John D. Schreier,Georgia B. McGaughey,Michael J. Bogusky,Christopher D. Cox,George D. Hartman,Richard G. Ball,C. Meacham Harrell,Duane R. Reiss,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger	12
11	Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman,John D. Schreier,Anthony J. Roecker,Swati P. Mercer,Georgia B. McGaughey,Christopher D. Cox,George D. Hartman,C. Meacham Harrell,Duane R. Reiss,Scott M. Doran,Susan L. Garson,Wayne B. Anderson,Cuyue Tang,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger	21
12	2-Aminobenzophenones as a Novel Class of Bradykinin B₁Receptor Antagonists 2008 ·Journal of Medicinal Chemistry ·Dai‐Shi Su,(unknown),(unknown),Bang-Lin Wan,Kathy Murphy,Duane R. Reiss,C. Meacham Harrell,(unknown),(unknown),Raymond S.L. Chang,Douglas J. Pettibone,(unknown),Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Mark G. Bock,Neville J. Anthony	13
13	Proline bis-amides as potent dual orexin receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman,Anthony J. Roecker,Swati P. Mercer,Rodney A. Bednar,Duane R. Reiss,Richard W. Ransom,C. Meacham Harrell,Douglas J. Pettibone,Wei Lemaire,Kathy Murphy,Chunze Li,Thomayant Prueksaritanont,Christopher J. Winrow,John J. Renger,Kenneth S. Koblan,George D. Hartman,Paul J. Coleman	54
14	Potent bradykinin B1 receptor antagonists: 4-Substituted phenyl cyclohexanes 2007 ·Bioorganic & Medicinal Chemistry Letters ·Dai‐Shi Su,(unknown),(unknown),Bang-Lin Wan,Kathy Murphy,Duane R. Reiss,C. Meacham Harrell,(unknown),(unknown),Raymond S.L. Chang,Douglas J. Pettibone,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Mark G. Bock	5
15	Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1 2005 ·Biochemical and Biophysical Research Communications ·Sookhee Ha,(unknown),(unknown),C. Meacham Harrell,(unknown),Ray Chang,Tsing‐Bau Chen,Dai‐Shi Su,(unknown),Mark G. Bock,Roger Freidinger,Fred Hess	19
16	2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Dong-Mei Feng,Jenny Wai,Scott D. Kuduk,Christina Ng,Kathy Murphy,Richard W. Ransom,Duane R. Reiss,Raymond S.L. Chang,C. Meacham Harrell,Tanya MacNeil,Cuyue Tang,Thomayant Prueksaritanont,Roger Freidinger,Douglas J. Pettibone,Mark G. Bock	23
17	Generation and Characterization of a Human Bradykinin Receptor B1 Transgenic Rat as a Pharmacodynamic Model 2004 ·Journal of Pharmacology and Experimental Therapeutics ·J. Fred Hess,Richard W. Ransom,Zhizhen Zeng,Raymond S.L. Chang,Patricia J. Hey,(unknown),C. Meacham Harrell,(unknown),Tsing‐Bau Chen,Patricia Miller,Edward V. Lis,Duane R. Reiss,Raymond E. Gibson,(unknown),Robert M. DiPardo,Dai‐Shi Su,Mark G. Bock,Robert J. Gould,Douglas J. Pettibone	19
18	Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist 2004 ·European Journal of Pharmacology ·Richard W. Ransom,C. Meacham Harrell,Duane R. Reiss,(unknown),Raymond S.L. Chang,J. Fred Hess,Patricia Miller,Stacey O’Malley,(unknown),Priya Kunapuli,Dai‐Shi Su,(unknown),Michael A. Wallace,Conrad E. Raab,(unknown),Dennis Dean,Douglas J. Pettibone,Roger Freidinger,Mark G. Bock	18
19	Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies 2004 ·Bioorganic & Medicinal Chemistry Letters ·Dai‐Shi Su,(unknown),Kathy Murphy,Bang-Lin Wan,Matthew M. Zrada,C. Meacham Harrell,(unknown),J. Fred Hess,(unknown),Ray Chang,Michael A. Wallace,Conrad E. Raab,Dennis Dean,Douglas J. Pettibone,Roger Freidinger,Mark G. Bock	13
20	Characterization of the human oxytocin receptor stably expressed in 293 human embryonic kidney cells 1995 ·Life Sciences ·Jeffrey R. Jasper,C. Meacham Harrell,Julie A. O’Brien,Douglas J. Pettibone	38

About C. Meacham Harrell

C. Meacham Harrell is a scholar working on Endocrine and Autonomic Systems, Experimental and Cognitive Psychology and Genetics, having authored 24 papers that have together received 998 indexed citations. Recurring topics across this work include Sleep and Wakefulness Research (13 papers), Sleep and related disorders (11 papers) and Circadian rhythm and melatonin (10 papers). The work is most often cited by research in Endocrine and Autonomic Systems (531 citations), Experimental and Cognitive Psychology (511 citations) and Cognitive Neuroscience (606 citations). C. Meacham Harrell has collaborated with scholars based in United States. Frequent co-authors include Christopher J. Winrow, John J. Renger, Paul J. Coleman, Anthony L. Gotter, Susan L. Garson, Duane R. Reiss, Steven V. Fox, Pamela L. Tannenbaum, Joanne Stevens and Donghui Cui. Their work appears in journals such as Journal of the American Chemical Society, Scientific Reports and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact